HSPH1 and pulmonary arterial hypertension: Further studies indicated that 2H has good potential to treat pulmonary arterial hypertension (PAH).594 Meanwhile, it was the first inhibitor targeting candida albicans HSP110 (Msi3), significantly inhibits its chaperone activity with IC50 of 5.0 μM (Table 5).